Detection of Familial Hypercholesterolemia in South Africa via Cascade Screening
Experts in Familial hypercholesterolemia (FH) from the Medpace Central Lab were authors on a scientific poster presented at the American College of Cardiology’s 2018 Annual…
How to Identify, Enroll, and Retain Rare Disease Populations in Clinical Trials
Enrolling enough subjects into a rare disease study can seem like an insurmountable challenge, especially when you're looking at a subset of a rare disease,…
The Potential Power of the Human Microbiome for Drug Development
The dynamic nature of the microbiome is driving momentum and enthusiasm for clinical research. Recent advances in analyzing the microbiome and how it impacts immunity…
Key Issues to Consider When Initiating a Clinical Trial
In a recent article published in the November 2017 edition of the European Biopharmaceutical Review, experts from Medpace discuss key issues that need to be…
How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 1
In Part 1 of a 3 part blog series, we will explore how the heritability of neurological diseases and psychiatric diseases is changing the clinical…
New Whitepaper: The Microbiome in Clinical Trials – Opportunities and Challenges
Medpace and Diversigen discuss the opportunities and challenges of the microbiome in clinical trials in a recently published whitepaper. You can access the whitepaper in…
How to Avoid the Hidden Costs of Clinical Trials
The cost of conducting a clinical trial is indisputably expensive and time consuming. In this post, we present some practices that could help you execute…
Duchenne Muscular Dystrophy: Challenges in Clinical Research
Duchenne Muscular Dystrophy (DMD) is a specific type of muscular dystrophy characterized by muscle weakness and deterioration. DMD research comes with its fair share of…
Spotlight on Mexico – Rich in clinical research capabilities and benefits
Mexico is quickly becoming a major player in the pharmaceutical and medical device industries. It’s the number one exporter of medical devices in Latin America…
How important is patient-centricity in rare disease studies?
Patient-centricity is becoming increasingly important in all areas, but particularly in rare diseases. In this post, Dr. Richard Scheyer discusses the importance of patient-centricity in…